Cited by 40

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.

Paumier, Jean-Michel, Py, Nathalie A., García-González, Laura, Bernard, Anne, Stephan, Delphine, Louis, Laurence, Checler, Frédéric, Khrestchatisky, Michel, Baranger, Kévin, Rivera, Santiago·2019·The FASEB Journal

Abstract

We previously demonstrated that membrane type 1 (MT1) matrix metalloproteinase (MMP) was up‐regulated in the hippocampus of the model of transgenic mice bearing 5 familial mutations on human amyloid precursor protein (APP) and presenilin 1 of Alzheimer disease (AD), and that the proteinase increased the levels of amyloid β peptide (Aβ) and its APP C‐terminal fragment of 99 aa in a heterologous cell system. Here we provide further evidence that MT1‐MMP interacts with APP and promotes amyloidogenesis in a proteolytic‐dependent manner in Swedish APP‐expressing human embryonic kidney 293 (HEKswe) cells. MT1‐MMP–mediated processing of APP releases a soluble APP fragment, sAPP95. This process partly requires the activation of endogenous MMP‐2 but is independent of β‐site APP cleaving enzyme 1 (BACE‐1) or α‐secretase activities. In contrast, MT1‐MMP–mediated increase of Aβ levels involved BACE‐1 activity and was inhibited by tissue inhibitor of MMP‐2, a natural inhibitor of both MT1‐MMP and MMP‐2. Interestingly, near abolishment of basal Aβ production upon BACE‐1 inhibition was rescued by MT1‐MMP, indicating that the latter could mimic β‐secretase–like activity. Moreover, MT1‐MMP promoted APP/Aβ localization in endosomes, where Aβ production mainly occurs. These data unveil new mechanistic insights to support the proamyloidogenic role of MT1‐MMP based on APP processing and trafficking, and reinforce the idea that this proteinase may become a new potential therapeutic target in AD.—Paumier, J.‐M., Py, N. A., González, L. G., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., Rivera, S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP‐2 and BACE‐1 activities, and the modulation of APP trafficking. FASEB J. 33, 2910–2927 (2019). www.fasebj.org

Overview

Integrity signals

Registry

Crossref · 10.1096/fj.201801076r

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MT1-MMP upregulation in 5xFAD mice timely and spatially correlates with the increase in C99 levels, providing indirect in vivo support for the pro-amyloidogenic features of this MMP described in HEKswe cells.

    “MT1-MMP upregulation in 5xFAD mice timely and spatially correlates with the increase in C99 levels (Py et al., 2014), thus providing indirect in vivo support for the pro-amyloidogenic features of this MMP described in HEKswe cells (Paumier et al., 2019).”
  • About 50% of the sAPP95 released after MT1-MMP expression in HEKswe cells results from concerted action with MMP-2, MT1-MMP being the limiting factor in this enzymatic tandem.

    “It is estimated that about 50% of the sAPP95 released after MT1-MMP expression in HEKswe cells results from concerted action with MMP-2, MT1-MMP being in any case the limiting factor in this enzymatic tandem (Paumier et al., 2019).”
  • MT1-MMP can prominently increase Aβ levels in the HEK293 cell model of amyloidogenesis stably expressing APP with the familial Swedish mutation (HEKswe).

    “In complement of these results, we have recently reported that MT1-MMP can also prominently increase Aβ levels in the HEK293 cell model of amyloidogenesis, which stably expresses APP with the familial Swedish mutation (HEKswe) (Paumier et al., 2019).”
  • MT1-MMP could function as a surrogate β-secretase when BACE-1 is inhibited; this is supported by experiments in HEKswe cells where MT1-MMP restores basal levels of Aβ almost abolished by BACE-1 inhibitor IV (or C3).

    “Most interestingly, it has been proposed that MT1-MMP could also function as a surrogate β-secretase when BACE-1 is inhibited; this is supported by experiments in HEKswe cells where MT1-MMP is able to restore the basal levels of Aβ, almost abolished in the presence of BACE-1 inhibitor IV (or C3) (Paumier et al., 2019).”
  • MT1-MMP could favor amyloidogenic β-secretase processing by promoting APP sorting into BACE-1-enriched early endosomes.

    “Not exclusively, MT1-MMP could favor amyloidogenic β-secretase processing by promoting APP sorting into BACE-1-enriched early endosomes (Paumier et al., 2019).”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. 10.15252/emmm.201606210 · DOI · Paper page
  2. 10.1016/S0006-8993(00)02869-9 · DOI
  3. 10.1101/cshperspect.a006270 · DOI · Paper page
  4. 10.1186/1750-1326-9-48 · DOI
  5. 10.1016/j.neurobiolaging.2017.09.008 · DOI · Paper page
  6. 10.1111/j.1471-4159.2011.07584.x · DOI
  7. 10.1038/85064 · DOI
  8. 10.1016/B978-0-444-63486-3.00014-1 · DOI · Paper page
  9. 10.1016/0014-5793(96)00389-4 · DOI · Paper page
  10. 10.1074/jbc.275.16.12080 · DOI
  11. 10.1006/bbrc.1994.2872 · DOI
  12. Py N. A., 2014, Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP, Front. Aging Neurosci., 6, 247
  13. 10.1093/jb/mvj054 · DOI · Paper page
  14. 10.1007/s00018-015-1992-1 · DOI · Paper page
  15. Baranger K., 2017, MT5-MMP promotes Alzheimer's pathogenesis in the frontal cortex of 5xFAD mice and APP trafficking in vitro, Front. Mol. Neurosci., 9, 163, 10.3389/fnmol.2016.00163 · DOI · Paper page
  16. 10.1002/ijc.20459 · DOI
  17. 10.3727/096368912X657468 · DOI
  18. 10.1016/j.mcn.2008.08.004 · DOI
  19. 10.1371/journal.pone.0008289 · DOI
  20. 10.1074/jbc.M302622200 · DOI
  21. 10.1111/j.1365-2818.2006.01706.x · DOI
  22. 10.1186/1471-2202-6-68 · DOI · Paper page
  23. 10.1021/jm049379g · DOI · Paper page
  24. 10.1074/jbc.M200655200 · DOI · Paper page
  25. 10.1074/jbc.271.29.17119 · DOI
  26. 10.1042/bj3340345 · DOI
  27. 10.1111/j.1432-1033.1997.00751.x · DOI
  28. 10.1242/jcs.00063 · DOI
  29. 10.1126/scisignal.127re6 · DOI
  30. 10.1074/jbc.272.35.22086 · DOI
  31. 10.1074/jbc.M212264200 · DOI
  32. 10.1038/cddiscovery.2017.36 · DOI
  33. 10.1073/pnas.241293698 · DOI
  34. 10.1242/jcs.00710 · DOI
  35. 10.1021/bi901994d · DOI · Paper page
  36. 10.1016/j.bbamcr.2017.05.013 · DOI
  37. 10.1074/jbc.M111.252718 · DOI · Paper page
  38. 10.1074/jbc.M112.395608 · DOI · Paper page
  39. Bylander J. E., 2007, Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities. Biol, Chem., 388, 1163
  40. 10.1038/nn.2433 · DOI · Paper page
  41. 10.1523/JNEUROSCI.3467-10.2010 · DOI · Paper page
  42. 10.1111/j.1600-0854.2012.01332.x · DOI · Paper page
  43. 10.1016/j.cell.2016.05.020 · DOI · Paper page
  44. 10.1242/jcs.00643 · DOI · Paper page
  45. 10.1126/science.286.5440.735 · DOI · Paper page
  46. 10.1073/pnas.1100745108 · DOI
  47. Dunys J. Valverde A. andChecler F.(In press)Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease? [E-pub ahead of print]J. Biol. Chem
  48. 10.1523/JNEUROSCI.2085-06.2006 · DOI · Paper page
  49. 10.1074/jbc.274.27.18851 · DOI
  50. 10.1016/j.bbrc.2011.08.085 · DOI
  51. 10.1074/jbc.M113.481101 · DOI · Paper page
  52. 10.1038/ncomms9762 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Paumier, J.-M., Py, N. A., García-González, L., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S.
Affiliations
  • Aix-Marseille Univ CNRS INP Inst Neurophysiopathol Marseille France
  • Institut de Pharmacologie Moléculaire et Cellulaire (IPMC) Unité Mixte de Recherche (UMR) 7275 CNRS–Université Nice Sophia (UNS) Excellence Laboratory (Labex) Development of Innovaive Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DistAlz) Valbonne France
Venue
The FASEB Journal
Publisher
Wiley
Published
2018-10-17
Volume
33
Issue
2
Pages
2910-2927
ISSN
  • 0892-6638
  • 1530-6860
Cited by
40
References
9
Language
en
Funders
  • Centre National de la Recherche Scientifique
  • Aix-Marseille Université
  • Agence Nationale de la Recherche

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review